Supplemental Figure 2 from CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies

Authors:
  • SQSteven N. Quayle
    Steven N. Quayle
  • NGNatasha Girgis
    Natasha Girgis
  • DTDharma R. Thapa
    Dharma R. Thapa
  • ZMZohra Merazga
    Zohra Merazga
  • AHAlex Histed
    Alex Histed
  • MMMiguel Moreta
    Miguel Moreta
  • PRPaige Ruthardt
    Paige Ruthardt
  • SHSandrine Hulot
    Sandrine Hulot
  • ANAlyssa Nelson
    Alyssa Nelson
  • LKLauren D. Kraemer
    Lauren D. Kraemer

Abstract
Supplementary Figure 2. Flow cytometric characterization of PBMC expansion cultures.